Adverum Biotechnologies Announces 1-For-10 Reverse Stock Split To Be Effective March 21, 202
Portfolio Pulse from Benzinga Newsdesk
Adverum Biotechnologies announced a 1-for-10 reverse stock split, approved by its Board of Directors on March 8, to be effective on March 21, 2024. This adjustment will result in approximately 20.8 million shares of common stock outstanding.

March 18, 2024 | 8:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Adverum Biotechnologies' 1-for-10 reverse stock split will significantly reduce the number of shares outstanding to approximately 20.8 million.
Reverse stock splits are often executed to increase the market price of a company's shares, potentially making them more attractive to investors. However, the impact on the stock price can be uncertain as market perception varies. The reduction in shares outstanding could lead to a temporary increase in stock price due to perceived scarcity, but long-term effects depend on the company's performance and investor sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100